75000 - Document - Document and Entity Information
link:presentationLink
link:calculationLink
link:definitionLink
75010 - Statement - Condensed Balance Sheets
link:presentationLink
link:calculationLink
link:definitionLink
75020 - Statement - Condensed Balance Sheets (Parenthetical)
link:presentationLink
link:calculationLink
link:definitionLink
75030 - Statement - Condensed Statements of Operations and Comprehensive Loss
link:presentationLink
link:calculationLink
link:definitionLink
75040 - Statement - Condensed Statements of Stockholders' Equity
link:presentationLink
link:calculationLink
link:definitionLink
75050 - Statement - Condensed Statements of Cash Flows
link:presentationLink
link:calculationLink
link:definitionLink
995455 - Disclosure - Description of Business, Organization and Liquidity
link:presentationLink
link:calculationLink
link:definitionLink
995465 - Disclosure - Summary of Significant Accounting Policies
link:presentationLink
link:calculationLink
link:definitionLink
995475 - Disclosure - Fair Value Measurements
link:presentationLink
link:calculationLink
link:definitionLink
995495 - Disclosure - Long-Term Investments
link:presentationLink
link:calculationLink
link:definitionLink
995505 - Disclosure - Accrued Expenses and Other Current Liabilities
link:presentationLink
link:calculationLink
link:definitionLink
995515 - Disclosure - Significant Agreements
link:presentationLink
link:calculationLink
link:definitionLink
995525 - Disclosure - Commitments and Contingencies
link:presentationLink
link:calculationLink
link:definitionLink
995535 - Disclosure - Common Stock
link:presentationLink
link:calculationLink
link:definitionLink
995545 - Disclosure - Stock-Based Compensation
link:presentationLink
link:calculationLink
link:definitionLink
995555 - Disclosure - Segment Information
link:presentationLink
link:calculationLink
link:definitionLink
995565 - Disclosure - Net Loss Per Share
link:presentationLink
link:calculationLink
link:definitionLink
995575 - Disclosure - Subsequent Events
link:presentationLink
link:calculationLink
link:definitionLink
995585 - Disclosure - Summary of Significant Accounting Policies (Policies)
link:presentationLink
link:calculationLink
link:definitionLink
995595 - Disclosure - Fair Value Measurements (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995615 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995625 - Disclosure - Stock-Based Compensation (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995635 - Disclosure - Segment Information (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995645 - Disclosure - Net Loss Per Share (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
995655 - Disclosure - Description of Business, Organization and Liquidity - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995665 - Disclosure - Fair Value Measurements - Summary of Financial Assets Measured at Fair Value on Recurring Basis (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995675 - Disclosure - Fair Value Measurements - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995685 - Disclosure - Fair Value Measurements - Summary of Changes in Fair Value of Company's Level 3 Financial Assets (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995695 - Disclosure - Marketable Securities - Summary of Amortized Cost, Unrealized Gains (Losses) and Fair Value of Available-for-sale Marketable Securities (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995715 - Disclosure - Marketable Securities - Summary of Amortized Cost and Fair Value of Available-for-sale Marketable Securities by Contractual Maturity (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995725 - Disclosure - Long-Term Investments - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995735 - Disclosure - Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995745 - Disclosure - Significant Agreements - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995755 - Disclosure - Significant Agreements - Additional Information (Details1)
link:presentationLink
link:calculationLink
link:definitionLink
995755 - Disclosure - Significant Agreements - Additional Information (Details1) [Default]
link:presentationLink
link:calculationLink
link:definitionLink
995765 - Disclosure - Common Stock - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995775 - Disclosure - Stock-Based Compensation - Addition Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995785 - Disclosure - Stock-Based Compensation - Summary of Unvested Common Stock Activity (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995795 - Disclosure - Stock-Based Compensation - Summary of Profits Units Activity (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995805 - Disclosure - Stock-Based Compensation - Summary of Common Stock Option Activity (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995815 - Disclosure - Stock-Based Compensation - Summary of Common Restricted Stock Unit Activity (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995825 - Disclosure - Stock-based Compensation - Summary of Classification of Stock-based Compensation Expense (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995835 - Disclosure - Segment Information - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995845 - Disclosure - Segment Information - Summary of Results of Operations Provided to Company's CODM (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995855 - Disclosure - Net Loss Per Share - Schedule of Basic and Diluted Net Loss Per Share Attributable To Common Stockholders (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995865 - Disclosure - Net Loss Per Share - Summary of Outstanding Potentially Dilutive Securities that have been Excluded from Calculation of Diluted Net Loss Per Unit (Details)
link:presentationLink
link:calculationLink
link:definitionLink
995875 - Disclosure - Subsequent Events - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
Restricted Stock Subject to Future Vesting
Restricted stock subject to future vesting member.
Restricted Stock Subject to Future Vesting [Member]
Change in Accounting Principle, Type [Domain]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value
Weighted- Average Grant Date Fair Value, Vested
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
Weighted-Average Threshold Amount, Forfeited and expired
Proceeds from Sale of Property, Plant, and Equipment
Proceeds from Sale of Property, Plant, and Equipment, Total
Proceeds from sale of property and equipment
Contingent consideration classified as equity fair value disclosure additional.
Contingent Consideration Classified as Equity Fair Value Disclosure Additional
Equity consideration estimated fair value, additional
Percentage added to cost of goods that represents price of manufactured components.
Percentage Added to Cost of Goods that represents Price of Manufactured Components
Percentage added to cost of goods that represents price of manufactured components
Common Unit, Outstanding
Common units, outstanding
Entity Incorporation, State or Country Code
Reimbursable expense received
Reimbursable expense received.
Reimbursable expenses received
Accrued personnel related expenses current.
Accrued Personnel Related Expenses Current
Accrued personnel related expenses
Preferred Stock, Shares Issued
Preferred stock, issued
Exercise Payment Reserve
Exercise payment reserve.
Exercise payment reserve
Increase (Decrease) in Accounts Payable, Total
Increase (Decrease) in Accounts Payable
Accounts payable
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One
Fair Value, Maturing within one year
Credits recognized within research and development expenses.
Credits Recognized Within Research And Development Expenses
Credits recognized within research and development expenses
Plan Name [Axis]
Equity [Abstract]
Exercise payment received
Exercise payment received.
Entity Current Reporting Status
US Government Agencies Debt Securities [Member]
Government Agency Obligations
U.S. Government Bonds
Denominator.
Denominator [Abstract]
Denominator
Repayment of Notes Receivable from Related Parties
Cash received in the form of convertible promissory note
Operating Expenses [Abstract]
Operating expenses:
Fair Value, Inputs, Level 2 [Member]
Level 2
Commitments and Contingencies Disclosure [Text Block]
Commitments and Contingencies
Metagenomi LLC.
Metagenomi L L C [Member]
Metagenomi LLC
Common Stock, Shares Authorized
Common stock, authorized
Other Ownership Interests, Units Outstanding
Profit interests, outstanding
Purchase of common stock.
Purchase of Common Stock
Purchase of common stock
Document Fiscal Period Focus
Issuance of common stock and restricted common stock In exchange for profits interests upon reorganization shares.
Issuance Of Common Stock And Restricted Common Stock In Exchange For Profits Interests Upon Reorganization Shares
Issuance of common stock and restricted common stock in exchange for profits interests upon Reorganization (in shares)
Entity Shell Company
Temporary Equity, Shares Outstanding
Redeemable convertible preferred units, outstanding
Beginning balance, (in shares)
Ending balance, (in shares)
Shares Outstanding
Other Accrued Liabilities, Current
Other accrued liabilities
Impairment losses on investments
Other Than Temporary Impairments Loss Debt Securities Available For Sale
Other-than-temporary impairments loss debt securities available-for-sale.
Reclassification of deferred offering costs paid.
Reclassification Of Deferred Offering Costs Paid
Reclassification of deferred offering costs paid in prior year to stockholders' equity
Cash and Cash Equivalents, at Carrying Value, Total
Cash and Cash Equivalent
Cash and cash equivalents
Amortized cost
Amortized Cost
Stock Issued During Period, Shares, Conversion of Units
Number of shares issued
Conversion of convertible preferred units, common units and profits interests to common stock (in units/shares)
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (shares)
Common Stock, Shares, Issued
Common stock, issued
Asset Class [Domain]
Statement [Table]
Restricted Cash, Noncurrent
Restricted cash
Interest Receivable
Accrued interest receivable included in prepaid expenses and other current assets
Stock options, weighted average exercise price granted
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Collaboration advance.
Collaboration advance
Collaboration advance
Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent
Purchase price of common stock percentage of fair value
Statement [Line Items]
Amortization of non-cash collaboration revenue.
Amortization of non-cash collaborations revenue
Amortization of non-cash collaboration revenue
Amortization of non-cash collaboration revenue
Effect of Change in Accounting Estimate, Type [Axis]
Entity Filer Category
Reimbursable internal costs and out-of-pocket costs incurred.
Reimbursable Internal Costs and Out-of-Pocket Costs Incurred
Reimbursable internal costs and out-of-pocket costs
Liabilities and Equity
Total liabilities, redeemable convertible preferred units and stockholders' equity / members' deficit
Total liabilities and stockholders' equity
Debt Instrument [Line Items]
Payables and Accruals [Abstract]
Payments to Acquire Marketable Securities
Purchases of available-for-sale marketable securities
Purchases of available-for-sale marketable securities
Stock options, weighted average exercise price exercisable ending balance
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Stock options, weighted average exercise price exercisable as of March 31, 2026
Conversion of stock shares outstaning.
Conversion Of Stock Shares Outstaning
Shares outstanding
Fair value
Cash and Cash Equivalents, Fair Value Disclosure
Subsequent Event [Line Items]
Options to Purchase Common Stock
Investment Income, Interest
Interest income
Deferred finance issuance costs included in accounts payable, accrued expenses and other current liabilities
Deferred finance issuance costs included in accounts payable, accrued expenses and other current liabilities
US Treasury Bond Securities [Member]
U.S. Government Bonds
Research and Development Arrangement, Contract to Perform for Others, Description and Terms
Agreement term description
Asset-backed Securities
Asset-Backed Securities [Member]
Common stock exercise price per share.
Common Stock Exercise Price Per Share
Common stock exercise price
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]
Summary of Results of Operations Provided to Company's CODM
Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited
Forfeiture of unvested common stock (shares)
Forfeiture of unvested common stock (in shares)
Extended Reasearch Term
Extended research term
Extended research term.
Conversion of Stock, Amount Converted
Conversion of redeemable convertible preferred stock to common stock upon initial public offering
Modification under asc seven one eight.
Modification Under ASC Seven One Eight [Member]
Modification Under ASC 718
Significant Accounting Policies [Text Block]
Summary of Significant Accounting Policies
Vesting [Domain]
Reimbursable internal costs and out-of-pocket costs incurred payable in quarterly installments.
Reimbursable Internal Costs and Out-of-Pocket Costs Incurred Payable in Quarterly Installments
Reimbursable internal costs and out-of-pocket costs payable in quarterly installments
Stock options, number of shares granted
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross
Profits interests.
Profits Interests [Member]
Profits Interests
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Schedule of Basic and Diluted Net Loss Per Share Attributable To Common Stockholders
Investment, Name [Axis]
Investments Classified by Contractual Maturity Date [Table Text Block]
Summary of Amortized Cost and Fair Value of Available-for-sale Marketable Securities by Contractual Maturity
Earnings Per Share, Basic, Total
Earnings Per Share, Basic
Net loss per share attributable to common stockholders - basic
Research and development cost received.
Research And Development Cost Received
Research and development costs received
Common stock purchase additional.
Additional purchase of common stock
Common Stock Purchase Additional
Other collaboration revenue .
Other Collaboration Revenue [Member]
Other
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Profit Interests, Outstanding, Beginning balance
Profit Interests, Outstanding, Ending balance
Percentage of Appointment Right
Percentage of appointment right.
Percentage of appointment right
Liabilities, Current
Total current liabilities
Development, option and license agreement.
Development, Option and License Agreement [Member]
Development, Option and License Agreement
Increase (Decrease) in Accounts Receivable
Accounts receivable
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]
Adjustments to reconcile net loss to net cash used in operating activities
Equity [Table]
Equity.
Development and regulatory milestone payment received.
Development And Regulatory Milestone Payment Received
Development and regulatory milestones payment received
Future regulatory approval milestone payments received.
Future Regulatory Approval Milestone Payments Received
Future regulatory approval milestone payments received
Employee's eligible annual compensation.
Employee's eligible annual compensation
Exploratory program member.
Exploratory Program [Member]
Exploratory Program
Consolidation Items [Domain]
Equity, Attributable to Parent [Abstract]
Stockholders' equity (deficit):
Summary of Changes in Fair Value of Company's Level 3 Financial Assets
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
Entity Small Business
Series A-2 Preferred Stock.
Series A-2 Preferred Stock [Member]
Series A-2 Preferred Units
Accrued research and development expenses.
Accrued Research and Development Expenses
Accrued research and development expenses
Retained Earnings (Accumulated Deficit), Total
Retained Earnings (Accumulated Deficit)
Accumulated deficit
Temporary equity stock issued value conversion of redeemable convertible preferred stock to common stock upon initial public offering.
Temporary Equity Stock Issued Value Conversion Of Redeemable Convertible Preferred Stock To Common Stock Upon Initial Public Offering
Conversion of redeemable convertible preferred stock to common stock upon initial public offering
Preferred Stock
Preferred Stock [Member]
Moderna DT Program [Member]
Moderna DT Program
Moderna DT program.
Proceeds from Issuance Initial Public Offering
Proceeds from issuance of common stock upon initial public offering, net of underwriting discounts and commissions and other offering costs
Proceeds from Issuance Initial Public Offering, Total
Share-Based Payment Arrangement [Text Block]
Stock-Based Compensation
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Affini T Therapeutics, Inc.
Affini T Therapeutics, Inc [Member]
Affini-T Therapeutics, Inc.
Affini-T
Share based compensation arrangement by share based payment award options exchanged for vested and unvested common stock in connection with the reorganization.
Share Based Compensation Arrangement By Share Based Payment Award Options Exchanged For Vested And Unvested Common Stock In Connection With The Reorganization
Profits Interests, Exchanged for vested and unvested common stock in connection with the Reorganization
Amendment Flag
Increase (decrease) in deferred revenue and collaboration advances
Increase (decrease) in deferred revenue and collaboration advances.
Deferred revenue and collaboration advance
Liabilities and Equity [Abstract]
Liabilities, Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit)
Entity Address, Postal Zip Code
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Net cash used in operating activities
Increase (Decrease) in Operating Lease Liability
Operating lease liabilities
Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description
Segment reporting, CODM, profit (loss) measure, how used, description
Common Stock [Member]
Common Stock
Fair Value of Investment Received as Collaboration Consideration
Fair value of investment received as collaboration consideration.
Fair value of investment received as collaboration consideration
Debt Securities, Available-for-Sale [Line Items]
Exercise payment
exercise payment
exercise payment
Metagenomi Inc.
Metagenomi Inc [Member]
Metagenomi Inc
Entity Address, Address Line One
Fair Value Hierarchy and NAV [Axis]
Earnings Per Share [Abstract]
Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Amortized Cost
Amortized Cost, Total available-for-sale marketable securities
Net Carrying Value
Beginning balance
Ending balance
Redeemable convertible preferred stock: zero shares authorized, issued and outstanding as of September 30, 2024; 41,813,375 shares authorized, issued and outstanding as of December 31, 2023; liquidation preference of $352,044 as of December 31, 2023
Temporary Equity, Carrying Amount, Attributable to Parent
Non refundable upfront collaboration payment received.
Non refundable upfront collaboration payment received
Investment Type [Axis]
Share-Based Payment Arrangement, Valuation Technique [Extensible Enumeration]
Operating Lease, Right-of-Use Asset
Operating lease right-of-use assets
OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax, Total
OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax
Unrealized loss on available-for-sale marketable securities
Additional exploratory cost reimbursements amount
Additional exploratory cost reimbursements amount.
Document Type
Research and Development Supplies and Services
Research and development supplies and services.
Research and development supplies and services
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
Entity Central Index Key
Debt Securities, Available-for-Sale [Table Text Block]
Summary of Amortized Cost, Unrealized Gains (Losses) and Fair Value of Available-for-sale Marketable Securities
Initial Public Offering Costs Included In Accounts Payable, Accrued Expenses And Other Current Liabilities
Initial public offering costs included in accounts payable, accrued expenses and other current liabilities.
Initial public offering costs included in accounts payable, accrued expenses and other current liabilities
Initial public offering costs included in accounts payable, accrued expenses and other current liabilities
Amortization of contract consideration amount.
Amortization of contract consideration amount
Investments, Debt and Equity Securities [Abstract]
Reimbursable expenses
Reimbursable expenses.
Reimbursable expenses
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Net increase (decrease) in cash, cash equivalents and restricted cash
Subsequent Event Type [Domain]
Sales-based milestones to be received.
Sales-Based Milestones to be Received
Sales-based milestones to be received
Series A-1 Preferred Stock.
Series A 1 Preferred Stock [Member]
Series A-1 Preferred Units
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Antidilutive securities
Cost sharing payables.
Cost Sharing Payables
Cost sharing payables
Common Stock, Par or Stated Value Per Share
Common stock, par value
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent, Total
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Other comprehensive income (loss)
Other comprehensive loss
Reduction in variable consideration.
Reduction in Variable Consideration
Reduction in variable consideration
Debt Securities, Available-for-Sale, Amortized Cost
Amortized Cost, Total available-for-sale marketable securities
Amortized Cost
Debt Securities, Available-for-Sale
Fair Value, Total available-for-sale marketable securities
Fair Value
Fututre sales-based milestones to be received
Futute sales based milestones to be received
Futute sales-based milestones to be received.
Moderna TX, Inc.
Moderna TX Inc [Member]
Moderna TX, Inc
Moderna
Stock options, number of shares outstanding beginning balance
Stock options, number of shares outstanding ending balance
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares
Stock shares canceled.
Stock Shares Canceled
Shares canceled
Investment [Text Block]
Long-Term Investments
Upfront payment received.
Upfront Payment Received
Upfront payment received
Common Unit, Authorized
Common units, authorized
Moderna RT program.
Moderna RT Program [Member]
Moderna RT Program
Share based compensation arrangements by share based payment award options canceled in connection with the reorganization weighted average exercise price.
Share Based Compensation Arrangements By Share Based Payment Award Options Canceled In Connection With The Reorganization Weighted Average Exercise Price
Weighted-average Threshold amount, Canceled in connection with the Reorganization
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Current Fiscal Year End Date
Schedule of Long-Term Debt Instruments [Table]
Document Quarterly Report
Entity Address, State or Province
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Number of Shares, Outstanding, Beginning balance
Number of Shares, Outstanding, Ending balance
Subsidiary of LLC or LP [Table]
Investment, Name [Domain]
Investment Owned, Balance, Shares
Number of shares investment owned
Preferred Stock, Shares Outstanding, Ending Balance
Preferred Stock, Shares Outstanding, Beginning Balance
Preferred Stock, Shares Outstanding
Preferred stock, outstanding
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive loss
Comprehensive loss
Unrealized Gains
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax
Common Stock, Capital Shares Reserved for Future Issuance
Common stock shares reserved/available for future issuance
Conversion of Stock, Shares Converted
Outstanding shares converted
Collaboration agreement upfront payment received.
Collaboration Agreement Upfront Payment Received
Collaboration agreement upfront payment received
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
Summary of Classification of Share-based Compensation Expense
Summary of Classification of Stock-based Compensation Expense
Professional services and consulting
Professional Fees
Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]
Accrued Expenses and Other Current Liabilities
Unvested Restricted Common Stock [Member]
Unvested Restricted Common Stock
Unvested restricted common stock.
Interest and Other Income
Interest and other
Estimated transaction price.
Estimated Transaction Price
Estimated transaction price
Collaborative Arrangement Disclosure [Text Block]
Significant Agreements
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Other comprehensive income (loss):
Common Stock Warrant Exercisable
Common stock warrant exercisable.
Warrant exercisable
Proceeds from Sale and Maturity of Marketable Securities
Maturities of available-for-sale marketable securities
Subsequent Event
Subsequent Event [Member]
Reimbursement for research costs.
Reimbursement for Research Costs
Reimbursement for research costs
Contract consideration transaction cost.
Contract consideration transaction cost
Transaction cost
Ionis member.
Ionis [Member]
Ionis
Other Assets, Noncurrent
Other assets
Debt Securities, Available-for-Sale, Current
Available-for-sale marketable securities
Antidilutive Securities [Axis]
Long term investments.
Long Term Investments [Member]
Long-term Investments
Total Available-for-sale Marketable Securities
Available-for-Sale Securities [Member]
AOCI Attributable to Parent [Member]
Accumulated Other Comprehensive Income (Loss)
Future development milestone payments to be received.
Future Development Milestone Payments to be Received
Future development milestone payments to be received
Cash and Cash Equivalents [Domain]
Preferred Stock, Value, Issued
Preferred stock: $0.0001 par value; 10,000,000 shares authorized and zero shares issued and outstanding
Minimum
Minimum [Member]
Weighted- Average Grant Date Fair Value, Granted
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
Financial Instrument [Axis]
Assets, Current [Abstract]
Current assets:
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]
Fair Value, Inputs, Level 3 [Member]
Level 3
Segment Reporting [Abstract]
Fair Value, Assets Measured on Recurring Basis [Table Text Block]
Summary of Financial Assets Measured at Fair Value on Recurring Basis
Liabilities, Current [Abstract]
Current liabilities:
Sales based milestones received
Sales based milestones received.
Sales Based Milestones Received
Other Ownership Interests, Units Authorized
Profit interests, authorized
Shares, Outstanding
Beginning balance, (in shares)
Ending balance, (in shares)
Accounts Receivable, after Allowance for Credit Loss, Current, Total
Accounts Receivable, after Allowance for Credit Loss, Current
Accounts receivable
Commitments and Contingencies
Commitments and contingencies (Note 8)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Weighted- Average Grant Date Fair Value, Outstanding, Beginning balance
Weighted- Average Grant Date Fair Value, Outstanding, Ending balance
General and Administrative Expense [Member]
General and Administrative Expenses
Accounts receivable, gross
Accounts Receivable, before Allowance for Credit Loss, Current
Effect of Change in Accounting Estimate, Type [Domain]
Forecast [Member]
Forecast
US Treasury Bill Securities [Member]
U.S. Treasury Bills
Moderna collaboration agreement and moderna convertible promissory note agreement.
Moderna collaboration agreement and moderna convertible promissory note agreement [member]
Moderna Collaboration Agreement and Moderna Convertible Promissory Note Agreement
Numerator.
Numerator [Abstract]
Numerator:
Contract consideration amount.
Contract consideration amount
Capital Expenditures Incurred but Not yet Paid
Purchases of property and equipment included in accounts payable, accrued expenses and other current liabilities
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Net loss
Accrued Income Taxes, Current
Income tax payable
2024 employee stock purchase plan.
2024 Employee Stock Purchase Plan [Member]
ESPP
Employee Stock Purchase Plan
Weighted Average Number of Shares Outstanding, Basic, Total
Weighted Average Number of Shares Outstanding, Basic
Weighted-average common shares outstanding
Weighted-average common shares outstanding - basic
Scenario [Axis]
Final payment to be forfeited.
Final Payment To Be Forfeited
Final payment to be forfeited
Share-Based Payment Arrangement, Plan Modification, Incremental Cost
Estimated total modification expense
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
ViTToria Investment [Member]
ViTToria Investment [Member]
ViTToria investment
Annual research and development costs reimbursement.
Annual Research And Development Costs Reimbursement
Annual research and development costs reimbursement
Subsequent Events [Text Block]
Subsequent Events
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition, Total
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
Stock-based compensation expense
Amortization of collaboration advance expense.
Amortization of Collaboration Advance Expense
Amortization of collaboration advance
Equity, Attributable to Parent
Beginning balance
Ending balance
Total stockholders' equity
Preferred Stock, Par or Stated Value Per Share
Preferred stock, par value
Basis of Accounting, Policy [Policy Text Block]
Basis of Presentation
Statement of Stockholders' Equity [Abstract]
Cash Equivalents [Member]
Less: Amounts Classified as Cash Equivalents
Use of Estimates
Use of Estimates, Policy [Policy Text Block]
Development, option and license agreement upfront equity consideration estimated fair value.
Development, Option and License Agreement Upfront Equity Consideration Estimated Fair Value
Development, option and license agreement upfront equity consideration estimated fair value
Common stock issuable upon settlement of profits interests.
Common Stock Issuable Upon Settlement Of Profits Interests [Member]
Common Stock Issuable Upon Settlement of Profits Interests
Entity Address, Address Line Two
Fair Value Disclosures [Text Block]
Fair Value Measurements
Noncash Investing and Financing Items [Abstract]
Supplemental disclosure of non-cash information
Accrued Liabilities and Other Liabilities
Accrued expenses and other current liabilities
Total accrued expenses and other current liabilities
Warrants purchased.
Warrants Purchased
Warrants purchased
Other Ownership Interests, Units Issued
Profit interests, issued
Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]
Plan Name [Domain]
Stockholders Equity [line Items]
Stockholders equity.
Revenue, Performance Obligation Satisfied over Time [Abstract]
Acuitas License Agreement [Member]
Acuitas license agreement.
Acuitas License Agreement
Contingent Consideration Classified as Equity, Fair Value Disclosure
Equity consideration estimated fair value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]
Equity Method Investment, Ownership Percentage
Percentage of voting shares
Business Description and Basis of Presentation [Text Block]
Description of Business, Organization and Liquidity
Weighted average number of shares outstanding basic before adjustments.
Weighted Average Number Of Shares Outstanding Basic Before Adjustments
Weighted-average common shares outstanding
Facilities And Overhead Costs
Facilities and overhead costs.
Facilities and overhead costs
Purchases percentage on employee's eligible annual compensation.
Purchases percentage on employee's eligible annual compensation
Number of shares of common stock.
Number of shares of common stock
Related and Nonrelated Parties [Axis]
Increase (Decrease) in Income Taxes Payable
Income tax payable
Entity Address, City or Town
Extended research terms.
Extended research terms
Extended research term
Number of Reportable Segments
Number of reportable segment
Security Exchange Name
Brian C. Thomas, Ph. D [Member]
Brian C. Thomas, Ph. D [Member]
Entity Bankruptcy Proceedings, Reporting Current
Counterparty Name [Axis]
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Net loss before provision for income taxes
Net loss before provision for income taxes
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Number of Shares
Stock options, number of shares forfeited/ Expired
Stock options, number of shares forfeited/expired
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value
Stock options, weighted average exercise price forfeited/expired
Antidilutive Securities, Name [Domain]
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation
Cash, cash equivalents and restricted cash at beginning of period
Cash, cash equivalents and restricted cash at end of period
Cash, cash equivalents and restricted cash at end of period
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]
Statistical Measurement [Domain]
Total current assets
Assets, Current
Share-Based Payment Arrangement, Expense
Share-based compensation expense
Recognized compensation expense
Document Period End Date
Title and Position [Axis]
Description of termination of agreement.
Description of termination of agreement
Termination of agreement description
Fair Value Hierarchy and NAV [Domain]
Number of shares, stock options exercisable ending balance
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number
Stock options, number of shares exercisable as of March 31, 2026
Temporary equity stock issued shares conversion of redeemable convertible preferred stock to common stock upon initial public offering.
Temporary Equity Stock Issued Shares Conversion Of Redeemable Convertible Preferred Stock To Common Stock Upon Initial Public Offering
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (shares)
Series A-5 Preferred Units
Series A-5 Preferred Stock.
Series A-5 Preferred Stock [Member]
Exercise fee description.
Exercise Fee Description
Exercise fee description
Statement of Financial Position [Abstract]
Restricted Stock Units
Restricted Stock Units (RSUs) [Member]
Foreign Debt Securities
Debt Security, Corporate, Non-US [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Redeemable Convertible Preferred Units [Member]
Redeemable Convertible Preferred Units
Antidilutive Security, Excluded EPS Calculation [Table]
Preferred units.
Preferred Units [Member]
Preferred Units
Vesting [Axis]
Class of Stock [Axis]
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Equity consideration shares received
Upfront equity consideration shares received.
Upfront Equity Consideration Shares Received
Upfront equity consideration shares received
Moderna [Member]
Moderna.
Moderna
Liabilities
Total liabilities
US Government Debt Securities [Member]
U.S. Government Bonds
Co-develop and co-commercialize the licensed products member.
Co-Develop and Co-Commercialize Licensed Products [Member]
Co-Develop and Co-Commercialize Licensed Products
Financial Instruments [Domain]
Estimated contract consideration.
Estimated contract consideration
Deferred revenue
Increase (Decrease) in Deferred Revenue
Warrants purchased price per share.
Warrants Purchased Price Per Share
Warrants purchased price per share
Restricted Cash, Total
Restricted Cash
Restricted cash
Restricted Stock
Restricted Stock [Member]
Weighted Average Number of Shares Outstanding, Diluted, Total
Weighted Average Number of Shares Outstanding, Diluted
Weighted-average common shares outstanding - diluted
Aggregate share purchase amount
Aggregate purchase price.
Aggregate Purchase Price
Entity File Number
Option price estimated fair value percentage on date of grant.
Option price estimated fair value percentage on date of grant
Other Income Expense [Member]
Other income expense
Other Income Expense
Cover [Abstract]
Prepaid Expense and Other Assets, Current
Prepaid expenses and other current assets
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Number of Shares, Forfeited
Investments [Domain]
Scenario [Domain]
US Treasury Securities [Member]
U.S. Treasury Bills
Number of Operating Segments
Number of operating segment
Sale of Stock [Domain]
Common shares of Affini-T received for collaboration revenue
Common shares of Affini-T received for collaboration revenue
Common shares of Affini-T received for collaboration revenue
Segment Reporting Disclosure [Text Block]
Segment Information
General and Administrative Expense, Total
General and Administrative Expense
General and administrative
Series B Preferred Stock [Member]
Series B Preferred Units
Series B Preferred Stock
Nonvested Restricted Stock Shares Activity [Table Text Block]
Summary of Unvested Common Stock Activity
Revenue from Contract with Customer, Including Assessed Tax
Revenue
Temporary Equity, Liquidation Preference
Liquidation preference
Aggregate Liquidation Preference
Manufactured components proceeds.
Proceeds from manufactured components
Manufactured Components Proceeds
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Total
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period
Profits Interests, Forfeited and expired
Subsequent Event [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period
Number of shares issued
Operating Lease, Expense
Non-cash lease expense
Stock options, weighted average exercise price outstanding beginning balance
Stock options, weighted average exercise price outstanding ending balance
Stock options, weighted average exercise price outstanding beginning balance
New Accounting Pronouncements, Policy [Policy Text Block]
Recently Issued Accounting Pronouncements
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Contract with Customer, Liability, Current
Deferred revenue
Weighted average number of unvested shares.
Weighted Average Number Of Unvested Shares
Less: Weighted-average unvested shares of common stock
Estimated fair value of shares received as equity consideration
Upfront equity consideration received.
Upfront Equity Consideration Received
Upfront equity consideration received
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period
Vesting period
Convertible promissory note agreement.
Convertible Promissory Note Agreement [Member]
Convertible Promissory Note Agreement
Change in fair value of Level 3 financial assets
Change in fair value of Level 3 financial assets.
Selected target member.
Selected Target [Member]
Selected Target
Contract assets
Contract assets
Increase (Decrease) in Contract with Customer, Asset
Depreciation, Total
Depreciation
Depreciation
Long-Term Investments, Total
Long-Term Investments
Carrying value of investment
Long-term investments
Common Stock, Shares, Outstanding
Common Stock, Shares, Outstanding, Beginning Balance
Common Stock, Shares, Outstanding, Ending Balance
Common stock, outstanding
Shares of common stock outstanding
Operating Lease, Liability, Current
Current portion of operating lease liabilities
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Revenue, Remaining Performance Obligation, Amount
Transaction price allocated to remaining performance obligations
Remaining performance obligation as revenue
Document Transition Report
Operating Expenses
Total operating expenses
Change in fair value included in other income (expense)
Change in fair value of long-term investments
Change in fair value of long-term investments
Change in fair value of long-term investments
Change in fair value of long-term investments
Change in fair value of long-term investments
Research and Development Expense, Total
Research and Development Expense
Research and development
Research and development supplies and services
Asset Impairment Charges, Total
Asset Impairment Charges
Loss on fixed assets write-off
Conversion of Stock, Amount Issued
Issuance of common stock and restricted common stock in exchange for profits interests upon Reorganization
Deferred Bonus and Profit Sharing Arrangement, Individual Contract, Type of Deferred Compensation [Domain]
Statement of Cash Flows [Abstract]
Stock Issued During Period, Value, New Issues
Issuance of common stock in connection with initial public offering, net of issuance costs
Summary of Profits Units Activity and Stock Option Activity
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
Preferred shares purchased
Purchase of preferred stock.
Purchase of Preferred Stock
Financing Receivable, Accrued Interest, Writeoff
Written off accrued interest receivable
Fair Value, Option, Changes in Fair Value, Gain (Loss)
Changes in fair value of investments
Gain (loss) related to changes in fair value of investments
Equity [Text Block]
Common Stock
Earnings Per Share [Text Block]
Net Loss Per Share
Technology milestone fees received.
Technology Milestone Fees Received
Technology milestone fees related to preclinical research objectives
Shares, Issued
Shares issued
Potential future Sales based milestones received
Potential future sales based milestones received.
Potential future sales based milestones received
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value
Beginning balance
Ending balance
Development regulatory and sales milestone payments.
Development Regulatory And Sales Milestone Payments
Development, regulatory and sales milestone payments
Net loss
Net loss
Milestone payment received.
Milestone Payment Received
Upfront payment received
Available-for-Sale Securities, Debt Maturities [Abstract]
Incentive stock options and non-qualified stock options.
Incentive Stock Options and Non-Qualified Stock Options
Description of termination of royalty term.
Description of termination of royalty term
Description of termination of royalty term
Assets [Abstract]
Assets
Prepaid expenses and other assets
Prepaid expenses and other assets
Increase (Decrease) in Prepaid Expense and Other Assets
Strategic collaboration and license agreement.
Strategic Collaboration and License Agreement [Member]
Strategic Collaboration and License Agreement
Document Fiscal Year Focus
At The Market Sales Agreement Remaining Capacity
ATM Sales Agreement Remaining Capacity.
ATM sales agreement remaining capacity
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]
Cash flows from investing activities
Accounts Payable, Current, Total
Accounts Payable, Current
Accounts payable
Research and Development Expense [Member]
Research and Development Expenses
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]
Marketable Securities
Series A-3Preferred Stock.
Series A-3Preferred Stock [Member]
Series A-3 Preferred Units
Certain vesting conditions.
Certain Vesting Conditions
Warrant exercisable.
Warrant Exercisable
Warrant exercisable
Deferred Revenue
Deferred Revenue, Total
Deferred revenue
Change in Accounting Principle, Type [Axis]
Exercise payment receivable
Exercise Payment Receivable
Exercise payment receivable.
Profits units activity.
Profits units activity [Member]
Profits Units Activity
Fair Value Disclosures [Abstract]
Collaboration agreement initial research term.
Collaboration Agreement Initial Research Term
Initial research term
Commitments and Contingencies Disclosure [Abstract]
Net Income (Loss) Available to Common Stockholders, Basic, Total
Net Income (Loss) Available to Common Stockholders, Basic
Net loss attributable to common stockholders
Option exercise fee paid.
Option Exercise Fee Paid
Option exercise fee paid per target
Increase in variable consideration
Increase In Variable Consideration
Increase in variable consideration.
Share-Based Payment Arrangement [Abstract]
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
Unrecognized compensation expense
Assets, Fair Value Disclosure, Total
Assets, Fair Value Disclosure
Fair value of assets
Sale of Stock [Axis]
Additional purchase of preferred stock
Purchase of preferred stock additional.
Purchase of Preferred Stock Additional
Potential future target selection fee
Potential future target selection fee.
Summary of Restricted Stock Unit Activity
Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]
Catch-up threshold amount based on estimated fair value of common unit.
Catch-up threshold amount based on estimated fair value of common unit
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Net cash provided by investing activities
Fair value of investment purchased in preferred stock purchase agreement
Fair Value of Investment Purchased in Preferred Stock Purchase Agreement
Fair value of investment purchased in preferred stock purchase agreement.
Title of 12(b) Security
Stock Issued During Period, Value, Conversion of Units
Conversion of redeemable convertible preferred stock to common stock upon initial public offering
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
Weighted- Average Grant Date Fair Value, Forfeited
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five
Amortized Cost, Maturing in one to five years
Money Market Funds [Member]
Money Market Funds (Included in Cash and Cash Equivalents)
Money Market Funds
Related and Nonrelated Parties [Domain]
Debt Securities, Available-for-Sale, Allowance for Credit Loss, Total
Debt Securities, Available-for-Sale, Allowance for Credit Loss, Beginning Balance
Debt Securities, Available-for-Sale, Allowance for Credit Loss, Ending Balance
Debt Securities, Available-for-Sale, Allowance for Credit Loss
Allowance for losses
Series A-4 Preferred Stock.
Series A-4 Preferred Stock [Member]
Series A-4 Preferred Units
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Temporary Equity, Shares Issued
Redeemable convertible preferred units, issued
Shares Issued
Provision For Income Taxes
Provision for income taxes.
Provision for income taxes
Other Liabilities, Noncurrent
Other non-current liabilities
Consolidated Entities [Axis]
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five
Fair Value, Maturing in one to five years
Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]
Changes in operating assets and liabilities:
Amendment to llc agreement.
Amendment To LLC Agreement [Member]
Amendment To LLC Agreement
Common stock issuable upon conversion of redeemable convertible preferred stock.
Common Stock Issuable Upon Conversion Of Redeemable Convertible Preferred Stock [Member]
Common Stock Issuable Upon Conversion of Redeemable Convertible Preferred Stock
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Weighted-Average Threshold Amount, Outstanding, Beginning balance
Weighted-Average Threshold Amount, Outstanding, Ending balance
Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised
Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised, Total
Proceeds from issuance of common stock under the equity incentive plan and ESPP
Debt Securities, Available-for-Sale, Purchased with Credit Deterioration, Amount at Purchase Price, Total
Debt Securities, Available-for-Sale, Purchased with Credit Deterioration, Amount at Purchase Price
Deterioration in creditworthiness of issuers of available-for-sale securities
Fair Value, Recurring and Nonrecurring [Table]
Additional Paid-in Capital [Member]
Additional Paid-In Capital
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
Accrued expenses and other current liabilities
Measurement Frequency [Domain]
Statement of Income Location, Balance [Axis]
Trading Symbol
Vested profits interests.
Vested Profits Interests
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One
Amortized Cost, Maturing within one year
Subsequent Event Type [Axis]
Target selection fee.
Target Selection Fee
Target selection fee
Non refundable upfront payment received.
Non Refundable Upfront Payment Received
Non-refundable upfront payment received
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]
Cash flows from financing activities
Fair Value, Recurring [Member]
Recurring
Entity Ex Transition Period
Interest and Debt Expense
Interest and Debt Expense, Total
Interest and other
Equity Components [Axis]
Remeasurement of operating right-of use asset and lease liability
Remeasurement of operating right-of use asset and lease liability.
Remeasurement of operating right-of use asset and lease liability
Nonoperating Income (Expense)
Total other income, net
Total other income, net
Equity Component [Domain]
Asset Class [Axis]
License fee
License fee.
IPO [Member]
Initial Public Offering
Subsidiary of Limited Liability Company or Limited Partnership [Line Items]
Common Unit, Issued
Common units, issued
Share based compensation arrangements by share based payment award options exchanged for vested and unvested common stock in connection with the reorganization weighted average exercise price.
Share Based Compensation Arrangements By Share Based Payment Award Options Exchanged For Vested And Unvested Common Stock In Connection With The Reorganization Weighted Average Exercise Price
Weighted-average Threshold amount, Exchanged for vested and unvested common stock in connection with the Reorganization
Stock Issued During Period, Shares, Employee Stock Purchase Plans
Shares issued under ESPP plan
Issuance of common stock under employee stock purchase plan (ESPP) (in shares)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period
Expiration period
Purchases of long-term investments
Payments to Acquire Long-Term Investments
Purchases of long-term investments
Common stock voting right description
Common Stock, Voting Rights
DT Co-Co Program
DT Co-Co Program [Member]
DT Co-Co program.
Maximum [Member]
Maximum
Statistical Measurement [Axis]
Contract with Customer, Liability, Noncurrent
Deferred revenue, non-current
Common Stock, Value, Issued
Common stock: $0.0001 par value; 500,000,000 shares authorized; 37,647,057 and 37,620,668 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively
Deferred Bonus and Profit Sharing Arrangements, Individual Contracts, Type of Deferred Compensation [Axis]
Description of Hybrid Instruments Accounted for at Fair Value
Description of hybrid instruments accounted for at fair value
Common stock for future issuance description.
Common stock for future issuance description
Future regulatory approval milestone payments received
Future regulatory approval milestone payment received
Future regulatory approval milestone payment received.
Issuance of common stock and restricted common stock in exchange for profits interests upon reorganization.
Issuance of common stock and restricted common stock in exchange for profits interests upon Reorganization
Issuance of common stock and restricted common stock in exchange for profits interests upon Reorganization
Future regulatory milestone payments to be received.
Future Regulatory Milestone Payments to be Received
Future regulatory milestone payments to be received
Royalty term expiration period.
Royalty term expiration period
Royalty term expiration period
Catch up.
Catch Up [Member]
Catch-Up
Preferred Stock, Shares Authorized
Preferred stock, authorized
Series A Convertible Preferred Stock [Member]
Series A Convertible Preferred Stock [Member]
Series A convertible preferred stock
Profit interest unit.
Profit Interest Unit [Member]
Profit Interest Unit
Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value
Fair Value, Total available-for-sale marketable securities
Employee Stock Option
Employee Stock [Member]
Entity Registrant Name
future developmental milestone payments received.
Future Developmental Milestone Payments Received
Future developmental milestone payments received
Target One
Target one member.
Target One [Member]
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax
Unrealized Losses
Entity Voluntary Filers
Cost - share percentage description.
Cost - Share Percentage Description
Cost - share percentage description
Other Nonoperating Income (Expense), Total
Other Nonoperating Income (Expense)
Other expense, net
Additional Paid in Capital, Total
Additional Paid in Capital
Additional paid-in-capital
Subsequent Events [Abstract]
JSC
JSC [Member]
JSC.
Preferred stock purchase price per share
Preferred stock purchase price per share.
Preferred Stock Purchase Price Per Share
At The Market Program [Member]
ATM Program.
ATM Program
Consolidated Entities [Domain]
Income Tax Expense (Benefit), Total
Income Tax Expense (Benefit)
Benefit from income taxes
Provision for income taxes
Provision for income taxes
Measurement Frequency [Axis]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Entity Common Stock, Shares Outstanding
Deferred Revenue, Revenue Recognized
Deferred revenue
Accumulated Other Comprehensive Income (Loss), Net of Tax, Total
Accumulated Other Comprehensive Income (Loss), Net of Tax
Accumulated other comprehensive income
Consolidation Items [Axis]
Payments to Acquire Property, Plant, and Equipment, Total
Payments to Acquire Property, Plant, and Equipment
Purchases of property and equipment
Number of Shares, Granted
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period
Assets
Total assets
Unvested common stock activity.
Unvested common stock activity [Member]
Unvested Common Stock Activity
Income Statement [Abstract]
Discovery program member.
Discovery Program [Member]
Discovery Program
Collaboration and license agreement member.
Collaboration and License Agreement [Member]
Collaboration and License Agreement
Stock Issued During Period, Shares, New Issues
Issuance of common stock in connection with initial public offering, net of issuance costs (in shares)
Temporary Equity, Shares Authorized
Redeemable convertible preferred units, authorized
Shares Authorized
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period
Number of Shares, Vested
Number of Shares, Vested
Earnings Per Share, Diluted, Total
Earnings Per Share, Diluted
Net loss per share attributable to common stockholders - diluted
Operating Segments [Member]
Operating Segments
Title and Position [Domain]
City Area Code
Impairment loss recognized
Other Than Temporary Impairments Loss Debt Securities Portion Recognized In Earnings
Other-than-temporary impairments loss debt securities portion recognized in earnings.
Counterparty Name [Domain]
Stock Issued During Period, Value, Employee Stock Purchase Plan
Issuance of common stock under employee stock purchase plan (ESPP)
Stock Issued During Period, Shares, Restricted Stock Award, Gross
Vesting of restricted stock units
Property, Plant and Equipment, Net, Total
Property, Plant and Equipment, Net
Property and equipment, net
Loss from operations
Loss from operations
Operating Income (Loss)
Operating loss
Retained Earnings [Member]
Accumulated Deficit
Cash and Cash Equivalents [Axis]
Share-Based Payment Arrangement, Noncash Expense, Total
Share-Based Payment Arrangement, Noncash Expense
Recognized compensation expense
Stock-based compensation expense
Payments of Stock Issuance Costs
Payments of initial public offering costs
Payments of initial public offering costs
Additional equity consideration shares received
Additional equity consideration shares received.
Additional Equity Consideration Shares Received
Target two member.
Target Two [Member]
Target Two
Operating Lease, Liability, Noncurrent
Non-current portion of operating lease liabilities
Fair Value, Inputs, Level 1 [Member]
Level 1
Disclosure Text Block [Abstract]
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Net cash used in financing activities
Investments, Fair Value Disclosure, Total
Investments, Fair Value Disclosure
Estimated fair value of investments
Nonoperating Income (Expense) [Abstract]
Other income (expense):
Potential future milestone payments receivable
Potential future milestone payments receivable.
Schedule of accrued expenses and other current liabilities.
Schedule Of Accrued Expenses And Other Current Liabilities Table TextBlock
Summary of Accrued Expenses and Other Current Liabilities
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
Summary of Outstanding Potentially Dilutive Securities that have been Excluded from Calculation of Diluted Net Loss Per Unit
Corporate Debt Securities [Member]
Corporate Debt Obligations
Debt Securities, Available-for-Sale [Table]
Entity Interactive Data Current
Statement of Income Location, Balance [Domain]
Share based compensation arrangement by share based payment award plan modification incremental compensation cost not yet recognized.
Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost not yet recognized
Expenses relating to modification expected to be recognized
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]
Cash flows from operating activities
Moderna DT and Moderna RT programs.
Moderna DT And Moderna RT Programs [Member]
Moderna DT and Moderna RT Programs
Series B-1 Preferred Stock.
Series B1 Preferred Stock [Member]
Series B-1 Preferred Units
Accretion (Amortization) of Discounts and Premiums, Investments
Accretion of discounts on available-for-sale marketable securities
Increase (Decrease) in Other Noncurrent Liabilities
Other non-current liabilities
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings
Change in fair value included in other income (expense), net
Loss related to change in fair value
Wave 2 target member.
Wave Two Target [Member]
Wave 2 Target
Entity Tax Identification Number
Revenues [Abstract]
Collaborations revenue
Collaborations revenue.
Local Phone Number
Board of Directors
Share-based payment arrangement, modification expense, cost not yet recognized, period for recognition.
Share-Based Payment Arrangement, Modification expense, Cost Not yet Recognized, Period for Recognition
Expected recognized period
Payment of deferred financing costs
Payments of Financing Costs
Payments of Financing Costs, Total
Accrued purchases of property and equipment.
Accrued Purchases of Property and Equipment
Accrued purchases of property and equipment
Accounting Policies [Abstract]
Reconciliation of cash, cash equivalents and restricted cash.
Reconciliation of cash, cash equivalents and restricted cash [Abstract]
Reconciliation of cash, cash equivalents and restricted cash
Revenue from Contract with Customer, Excluding Assessed Tax
Collaboration revenue
Total collaboration revenue
Cost sharing allocation expense
Cost sharing allocation expense.
Cost Sharing Allocation Expense
2024 stock option and incentive plan.
2024 Stock Option and Incentive Plan [Member]
2024 Plan
Class of Stock [Domain]
Commercial Paper [Member]
Commercial Paper
Employee-related expenses
Labor and Related Expense
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition
Weighted-average period
Long-Term Investments [Abstract]
Accrued Professional Fees, Current
Accrued legal and professional services
Cash, Cash Equivalents, and Short-Term Investments, Total
Cash, Cash Equivalents, and Short-Term Investments
Cash, cash equivalents and available-for-sale marketable securities
Share based compensation arrangement by share based payment award options canceled in connection with the reorganization in period.
Share Based Compensation Arrangement By Share Based Payment Award Options Canceled In Connection With The Reorganization In Period
Profits Interests, Canceled in connection with the Reorganization
Entity Emerging Growth Company